Understand the source comparison
Peptides for Healing: Tissue Type Comparison
BPC-157 Tendons, ligaments, GI mucosa Upregulates VEGF receptors, stabilizes nitric oxide Days 5–21 post-injury Strongest evidence in connective tissue repair; localized injection outperforms systemic TB-500 Muscle, ligaments, soft tissue Promotes actin polyme
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Tendons, ligaments, GI mucosa
- Upregulates VEGF receptors, stabilizes nitric oxide
- Days 5–21 post-injury
- Strongest evidence in connective tissue repair; localized injection outperforms systemic
- TB-500
- Muscle, ligaments, soft tissue
- Promotes actin polymerization, downregulates TNF-alpha
- Days 7–28 post-injury
- Accelerates cell migration into wound bed; timing during proliferation phase is critical
- GHRP-6
- Cartilage, bone, systemic anabolism
- Stimulates endogenous GH/IGF-1 release
- Chronic use (8–12 weeks minimum)
- Indirect mechanism; unsuitable for acute injury but valuable in degenerative conditions
- KPV
- Inflammatory modulation (all tissues)
- Inhibits NF-kB in macrophages
- Days 0–7 post-injury
- Controls early inflammation that delays later repair phases; pairs well with angiogenic peptides